Explaining the Importance of Molecular Testing to Patients With NSCLC

Presented by

AONN

Sponsored by

AstraZeneca

The Academy of Oncology Nurse & Patient Navigators (AONN+) is pleased to introduce an educational video in which expert nurse navigators and nurse practitioners discuss how to explain the importance of molecular testing to patients with resectable or metastatic non-small cell lung cancer in a way that patients and caregivers can understand.

This video is part 3 of a 5-part educational video series we’ve produced in partnership with AstraZeneca. Topics of discussion in this video include:

  • How do you explain the importance of molecular testing to patients?
  • What are some of the challenges you see with molecular testing and how are you overcoming them?
  • How does your institution handle molecular testing in resectable non-small cell lung cancer?
  • How do you handle molecular testing in metastatic non-small cell lung cancer?
  • What do you most want community nurse navigators and nurse practitioners to know about molecular testing for patients with resectable and metastatic non-small cell lung cancer?

Jean Edward, PhD, RN, CHPE

Assistant Professor, College of Nursing; Nurse Scientist
Markey Cancer Center, University of Kentucky, Lexington, KY
Last modified: June 1, 2022

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
     
    Profession or Role
    Primary Specialty or Disease State
    Country